Size of Beads in Drug Products Labeled for Sprinkle Rev1: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 16, 2012
April 24, 2020
e91280a2-a51b-4821-8bdc-f85a7743af01
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications
Guidance DocumentMay 6, 2011Center for Drug Evaluation and Research
ANDAs: Impurities in Drug Products: Guidance for Industry
Guidance DocumentNovember 29, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox